ProPhase Labs to Present at August 20th Virtual Investor Summit Microcap Event
ProPhase Labs (NASDAQ: PRPH), a next-generation biotech, genomics, and diagnostics company, has announced its participation in the Virtual Investor Summit Microcap Event on August 20th, 2024.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
ProPhase Labs (NASDAQ: PRPH), a next-generation biotech, genomics, and diagnostics company, has announced its participation in the Virtual Investor Summit Microcap Event on August 20th, 2024. The company will deliver a presentation at 1:00 P.M. ET and be available for one-on-one meetings throughout the day.
The event, themed around 50 micro-cap companies with catalysts and/or strong market performance, offers investors an opportunity to engage with ProPhase Labs directly. The presentation will be accessible via webcast, allowing remote participation. This summit provides a platform for in-depth discussions with top investors in the microcap space and includes a live Q&A session.
Details
News Market Reaction – PRPH
The recorded move for PRPH in the trading session of this news was +17.60%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
GARDEN CITY, NY, Aug. 19, 2024 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH) (“ProPhase” or the “Company”), a next-generation biotech, genomics, and diagnostics company, today announced that it will be presenting at the Virtual Investor Summit Microcap Event. The company will be available for 1-on-1 meetings throughout the day in addition to their presentation.
Event: Q3 Investor Summit
Date: August 20th, 2024
Presentation Time: 1:00 P.M. ET
Location: https://www.webcaster4.com/Webcast/Page/3062/51116
- The theme is 50 micro-cap companies with a catalyst and/or strong performance in the current market.
- Take a deep dive with the best Investors in MicroCap
- Live Q & A
- Complimentary to Qualified Investors. Please REGISTER HERE.
About ProPhase Labs
ProPhase Labs Inc. (Nasdaq: PRPH) (“ProPhase”) is a next-generation biotech, genomics and diagnostics company. Our goal is to create a healthier world with bold action and the power of insight. We’re revolutionizing healthcare with industry-leading Whole Genome Sequencing solutions, while developing potential game changer diagnostics and therapeutics in the fight against cancer. This includes a potentially life-saving cancer test focused on early detection of esophageal cancer and potential breakthrough cancer therapeutics with novel mechanisms of action. Our world-class CLIA labs and cutting-edge diagnostic technology provide wellness solutions for healthcare providers and consumers. We develop, manufacture, and commercialize health and wellness solutions to enable people to live their best lives. We are committed to executional excellence, smart diversification, and a synergistic, omni-channel approach. ProPhase Labs’ valuable subsidiaries, their synergies, and significant growth underscore our multi-billion-dollar potential.
For more information, visit www.ProPhaseLabs.com.
Media Relations and Institutional Investor Contact:
ProPhase Labs, Inc.
267-880-1111
investorrelations@prophaselabs.com
Retail Investor Relations Contact:
Renmark Financial Communications
John Boidman
514-939-3989
Jboidman@renmarkfinancial.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.